News

Banner’s valproic acid delayed release soft gelatin capsules is approved for use in the treatment of manic episodes associated with bipolar disorder, as monotherapy and adjunctive therapy in

New Enterprise Associates and Johnson & Johnson Development were the co-lead investors. Other participants in this round included existing investors BBT Fund, Thomas Weisel Healthcare Venture Partners, InterWest

These generic versions of divalproex sodium delayed release 125mg, 250mg, and 500mg (valproic acid activity) tablets are bioequivalent to Depakote delayed release tablets distributed by Abbott Laboratories. Divalproex

The company’s recently acquired JAS Diagnostic unit is the distributor for the Liasys analyzer in the US and supplier of the associated chemistry reagents. JAS prepared and submitted

The filing is based on data from the pivotal Phase III chronic lymphocytic leukaemia (CLL) 8 study, initiated by the German CLL Study Group, which showed at interim

The committee’s vote was made after Roche presented results from five Phase III clinical trials. The clinical development program was designed to evaluate the effects of Actemra on

This contract will cover the Equinoxe Shoulder product line. The award is a three-year agreement effective August 1, 2008. Bob Purcell, vice president of sales at Exactech, said:

According to Bridge Laboratories, construction of the new laboratory will begin in the fourth quarter of 2008. This facility, expected to be completed in late fourth quarter of

Protein Sciences company (PSC) has cited multiple breaches by Emergent including disclosure and mischaracterization of PSC’s material confidential information obtained from PSC during due diligence and Emergent’s failure